Our results show that treatment with MRS restored the expression of SIRT3, which was decreased by hemorrhagic shock and resuscitation; this restoration of SIRT3 levels likely occurred via upregulated expression of PGC-1α. This evidence concerns the gene PPARGC1A and Shock.